# Message test — https://www.kpunkt.net/ After reading your page, only 0 of 15 personas would take a meeting to learn more. - **Page tested:** https://www.kpunkt.net/ - **Audience tested against:** Decision makers in Health tech companies and applied research - **Personas:** 15 simulated - **Report:** https://grader.wynter.com/r/kpunkt-b2b-technology-marketing-HeowQhI > These answers are generated by AI, scored on Wynter's B2B Message > Layers framework using behaviorally-diverse simulated personas. The > methodology is real and the critique is directional. What a simulated > persona cannot have is a live budget, a renewal coming up, or a boss > asking about this quarter. --- ## 01 · The scores Every persona answered all four questions. These are four independent proportions of the same panel, not stages of a funnel. | Layer | Question | Cleared the bar | Strength | Of those who passed | | --- | --- | --- | --- | --- | | 1. Clarity | Do they understand what you do? | 15/15 | 88% | 7 without hesitation, 8 with reservations | | 2. Relevance | Can they tell what it solves, and who it's for? | 8/15 | 52% | all with reservations | | 3. Value | Do they actually want it? | 0/15 | 15% | — | | 4. Differentiation | Is there a reason to pick you over the alternatives? | 0/15 | 16% | — | **Brand alignment** (a side metric, not one of the four layers) — 2/15, 30% strength (all with reservations). Does the page read like the company you actually are? **Fix first: Relevance.** Earliest failing layer, walking the sequence in order — not simply the lowest score. --- ## 02 · What to change, layer by layer Ordered worst-first. Specific edits, not a restatement of the score. ### Value **Add client name, metric and timeframe under each Work item in the portfolio list** The Work list shows only titles like "Brand development" and "Customer Story Project" with no client, result, or date. Label each with the client, what changed, and by how much. *effort medium · impact high · tested against Proof next to the claim* **Expand the Philips entry into a short case summary with the outcome** Philips appears as a project title only, so a buyer cannot tell what KPUNKT did or what it achieved. Add two lines: the challenge, the work, and the measurable result. *effort medium · impact high · tested against Proof next to the claim* **Replace "That's the value of a true partnership" with a stated client result** The Partner section argues for long-term planning without a single number or named outcome to back it. Swap the closing line for something like average client tenure or a launch result. *effort low · impact medium · tested against Specifics beat superlatives* ### Differentiation **Add a section under Services stating who KPUNKT is chosen over and why** Nothing on the page says why a healthcare marketing lead would pick a 19-person firm over a larger one. Name the specific edge: regulated-market experience, senior staff on every project, speed to first draft. *effort medium · impact high · tested against Give a reason to choose you* **Rewrite the three service blurbs to name distinct deliverables and situations** "Agency support", "Strategic development" and "Innovation partner" all promise help with marketing challenges in the same vague verbs. Give each a named deliverable and the moment a buyer needs it, such as an NPI launch or a rebrand. *effort medium · impact high · tested against Tie the feature to the outcome* **Explain what Kanuu.net does in one line where it is first named** Kanuu.net appears under "Innovation partner" as a subsidiary with no explanation of its work. State what it builds and what it adds that KPUNKT alone cannot deliver. *effort low · impact medium · tested against Plain language* ### Relevance **Add the engagement model and typical project scope under "Let's talk about your project"** Buyers cannot tell whether this is retainer marketing support, a one-off strategy project, or something built and handed over. Say what a typical engagement covers, how long it runs, and what the client gets. *effort medium · impact high · tested against Answer the live objection* **State in the hero which marketing roles and company types KPUNKT works with** "Passion for healthcare and life science" leaves buyers guessing whether it means medtech, pharma, or diagnostics, and which role it serves. Name the buyer: marketing directors at medtech and life science manufacturers. *effort low · impact high · tested against Name the audience* ### Brand alignment (side metric) **Replace "Refreshing B2B solutions" with the job KPUNKT does for healthcare marketers** The headline could sit on any B2B firm's site and says nothing about the work. Lead with the specific job, such as taking medtech product launches from strategy to campaign. *effort low · impact high · tested against Concrete over abstract* **Name the problem healthcare marketing teams face above the Services section** The page opens with what KPUNKT is and jumps to what it sells, never naming the pressure the reader already feels. Write two lines on the launch deadline, regulatory review, or thin in-house team the buyer recognises. *effort medium · impact medium · tested against Problem before solution* **Add a line beside "19 people" explaining how projects are staffed and scaled** The headcount raises capacity doubts that the page never answers. Say who works on an account, typical project size, and how peak workload is handled. *effort low · impact medium · tested against Answer the live objection* --- ## 03 · What the personas said ### Service descriptions blur into one another Three respondents said agency services, strategy, and innovation consulting overlap without clear boundaries, using the same vague verbs. One could not tell where one service ended and the next began. > the service descriptions blur together — "Agency support," "Strategic development," and "Innovation partner" all use the same fuzzy verbs (boost efficiency, build tools, deliver support) so I couldn't tell where one service ends and another begins > > — Marketing Manager, Medical Device, 51-200 > those three labels overlap so much I can't tell where agency-support work ends and strategy or innovation consulting begins > > — VP of Marketing, Pharmaceuticals, 501-1000 ### The page reads as an agency, not the software platform respondents were evaluating Six respondents identified KPUNKT as a service agency rather than a software or automation platform, and said this places it in the wrong category for their evaluation and budget. Two noted positioning language actively confuses which it is. > phrases like "one-stop shop agency partner" and "innovation partner" sound like they could describe a platform vendor's positioning too > > — Marketing Manager, Medical Device, 51-200 > this isn't relevant to my search for a marketing automation platform at all — wrong category, I'd have closed the tab once I realized it's an agency, not a tool. > > — Marketing Manager, Medical Device, 51-200 > not a tool that solves managing complex stakeholder communications inside a platform. So no, not worth a meeting right now — it's the wrong category for what I'm evaluating; if I ever needed outsourced agency support alongside my automation stack, maybe, but that's a different budget line and a different conversation. > > — Marketing Manager, Medical Device, 51-200 > it's not a software tool at all — it's a services agency, not a marketing automation platform > > — Marketing Manager, Medical Device, 51-200 ### The problem statement is vague and the Kanuu.net subsidiary is unexplained Two respondents flagged unclear content: the problem the firm solves is stated vaguely despite a clear audience definition, and a subsidiary is named with no explanation of what it does. > There's a "Kanuu.net" subsidiary mentioned for "innovation partner" work, but it's not explained, so I can't tell if that's a platform or just another agency service. > > — Senior Marketing Manager, Life Sciences, 5000+ ### Agency positioning disqualifies the page from consideration for buyers seeking platform… Four respondents said outsourced agency services sit in a separate budget and conversation from software procurement. One specified needing platform dashboards and integrations, not agency services. > I'd need to see it framed as software I or my team would log into — screen shots of a dashboard, an integration list (Veeva, Salesforce, HCP consent management) > > — Marketing Manager, Medical Device, 51-200 > If they showed a specific case where they replaced or outperformed a brand management platform for a healthcare client — with a before/after on speed of rollout or consistency of brand assets across markets — that's the only thing that would get me to take a call > > — Director of Marketing, Healthcare, 1001-5000 > There's nothing here that competes with a brand management tool: no product screenshots, no integration details, no pricing, no metrics > > — Director of Marketing, Healthcare, 1001-5000 ### No case study carries a client name, metric, or outcome Ten respondents said the page offers no named clients, numbers, or measurable results to substantiate its claims. Work samples and project lists appear unlabeled, which several called the opposite of a reason to act. > there's nothing here to tell me it would work — no named pharma or life science clients, no case study with a metric like "cut launch prep time by X%" > > — VP of Marketing, Pharmaceuticals, 501-1000 > A named biotech or med-tech client my size, with a specific NPI launch and a result attached — 'we helped X hit launch in Y timeframe' — not just a category description of who they serve. > > — Chief Marketing Officer, Biotechnology, 201-500 > Nothing here — no case study numbers, no named client outcome, no before/after — tells me they'd actually do that better than my current agency roster > > — Senior Marketing Manager, Life Sciences, 5000+ > "boost the efficiency of your marketing campaigns, NPIs and more" is a generic claim with no specifics, no case numbers, no before/after. > > — Senior Marketing Manager, Life Sciences, 5000+ > the complete absence of proof behind the work samples. Labels like "Branding and product intro" or "Strategic marketing partnership" with zero metrics, no client names, no before/after — that's the opposite of a reason to act. > > — Marketing Manager, Medical Device, 51-200 > No numbers or case results though - no client names, no metrics on campaign lift or launch success > > — VP of Marketing, Pharmaceuticals, 501-1000 > "boost the efficiency of your marketing campaigns, NPIs and more" is a promise, not a case study. If they showed me a named biotech or pharma client where an NPI launch hit a specific timeline or budget target because of them, I'd take the meeting. > > — Chief Marketing Officer, Biotechnology, 201-500 > no case study metrics, no named client outcomes beyond a vague Philips project title > > — Director of Marketing, Healthcare, 1001-5000 > nothing on this page gives me a number to hang that on. No case study saying "cut time-to-market by X" or "reduced campaign costs by Y%" — just a client list-style "Work" section with tags like "Innovation" and "Strategy" and no substance behind the links. > > — Chief Marketing Officer, Biotechnology, 201-500 ### Respondents could not name anything separating KPUNKT from larger competitors or brand… Three respondents said the page offers no product differentiation against brand management platforms and no named client outcome to distinguish it from larger firms. One would need a case study proving platform outperformance before engaging. > What would rule them in: a named pharma or life science client with a specific metric ("reduced launch timeline by X weeks for [brand]"), because that's the only thing that would tell me my team's workload actually goes down > > — VP of Marketing, Pharmaceuticals, 501-1000 > A named pharma case with the actual friction point I recognize — something like 'MLR review was adding 6 weeks to NPI launches, we restructured the approval workflow and cut it to 2' — not just industry name-drops. > > — VP of Marketing, Pharmaceuticals, 501-1000 ### Small size raises unaddressed bandwidth and growth questions, and agency language… Two respondents said the boutique scale signals stability but prompts doubts about capacity and offers no growth narrative. One said agency vocabulary used without backing evidence puts off demanding buyers. > the tone itself doesn't feel written for a skeptical buyer who signs the check; it's agency-speak aimed at whoever likes phrases like "one-stop innovation partner" > > — Director of Marketing, Healthcare, 1001-5000 > it's not a huge global agency, more a niche outfit that's been around long enough to not be a startup risk, but small enough that I'd wonder about bandwidth > > — Senior Marketing Manager, Life Sciences, 5000+ > Small boutique shop — they say it themselves: "Founded in 1998, 19 people, 2 offices" (Eindhoven and Stuttgart). So an established but tiny agency, decades old but never scaled, which tells me they're a niche specialist rather than a growth story. > > — Senior Marketing Manager, Life Sciences, 5000+ ### The Philips project is the only credibility signal and it is stripped of detail Four respondents singled out Philips as the sole concrete proof point on the page, but noted it carries no outcome, performance figure, or timeline. It functions as a name only. > The "Work" section just lists project titles like "Philips Visual Patient Avatar simulator" and "Branding and product intro" with tags like Innovation/Assets/Strategy, but there's no actual case study content — no client outcome, no metric, no before/after > > — Senior Marketing Manager, Life Sciences, 5000+ > the client list under "Work" (Philips Visual Patient Avatar, a workflow simulator) is the only thing that catches my eye, since Philips is a real, recognizable healthcare name. But there's no story attached — no outcome, no timeline > > — Chief Marketing Officer, Biotechnology, 201-500 > The one specific, checkable thing is the Philips Visual Patient Avatar simulator project — that's a named client and a concrete deliverable > > — Director of Marketing, Healthcare, 1001-5000 --- ## 04 · The hardest read An adversarial pass over the findings. Every claim below was checked against the panel's own answers; unsupported ones were dropped. - **The page cannot survive a category check: buyers evaluating software land on an agency and stop.** *(high)* Six respondents read KPUNKT as a service agency rather than a platform, two said the positioning language actively confuses the two, and four placed agency services in a separate budget entirely. Misfiled pages never reach a shortlist. - **Evidence is the page's single largest failure, not a gap to patch later.** *(high)* Ten respondents found no named client, number, or measurable outcome, and unlabeled work samples were called the opposite of a reason to act. This is the highest-agreement finding on the page. - **Philips is being asked to carry proof it cannot carry.** *(high)* Four respondents named Philips as the sole concrete signal while noting it has no outcome, figure, or timeline, and ten found no substantiating metric anywhere. A logo without a result is decoration. - **Differentiation is impossible to assess because the page withholds the only inputs that would prove it.** *(high)* Three respondents could name nothing separating KPUNKT from larger firms or brand management platforms, and one required a case study proving platform outperformance — precisely what the ten respondents citing missing outcomes did not find. - **Vague verbs compound the category error rather than sitting beside it.** *(medium)* Three respondents said agency, strategy, and innovation offerings blur using the same vague verbs, and two found the core problem statement vague despite a clear audience. Indistinct services read as agency work by default. - **Boutique scale is presented as an unanswered liability.** *(medium)* Two respondents said the small size prompts capacity doubts with no growth narrative, and one said agency vocabulary without backing evidence puts off demanding buyers. Unsupported claims from a small firm read as overreach. --- ## 05 · Who answered | # | Role | Industry | Company size | | --- | --- | --- | --- | | 1 | VP of Marketing | Pharmaceuticals | 501-1000 | | 2 | Director of Marketing | Healthcare | 1001-5000 | | 3 | Senior Marketing Manager | Life Sciences | 5000+ | | 4 | Marketing Manager | Medical Device | 51-200 | | 5 | Chief Marketing Officer | Biotechnology | 201-500 | | 6 | VP of Marketing | Pharmaceuticals | 501-1000 | | 7 | Director of Marketing | Healthcare | 1001-5000 | | 8 | Senior Marketing Manager | Life Sciences | 5000+ | | 9 | Marketing Manager | Medical Device | 51-200 | | 10 | Chief Marketing Officer | Biotechnology | 201-500 | | 11 | VP of Marketing | Pharmaceuticals | 501-1000 | | 12 | Director of Marketing | Healthcare | 1001-5000 | | 13 | Senior Marketing Manager | Life Sciences | 5000+ | | 14 | Marketing Manager | Medical Device | 51-200 | | 15 | Chief Marketing Officer | Biotechnology | 201-500 | --- ## 06 · Before you act on this The methodology is real, and the critique is directional. What a simulated persona cannot have is a live budget, a renewal coming up, or a boss asking about this quarter. **Validate anything you're betting on with real ICPs who are actually in-market.** Being wrong is more expensive than you think. Finding out is cheaper than you'd guess. Wynter runs message testing with verified B2B professionals — trusted by HubSpot, RingCentral, Shopify, Cognism, Paddle, Veeam, Rippling and Miro. This report is kept for 60 days from 2026-09-06, then deleted along with the personas and their answers.